List of insiders holdings for NovoCure Ltd:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| DOYLE WILLIAM F WFD Ventures Fund II L.P. Executive Chairman 10% Owner | 2017-03-09 17:08:22 | 84,699 20,401,721 | 20,486,420 | Form 4 |
| Wyss Hansjoerg 10% Owner | 2021-02-01 12:08:58 | 8,141,397 0 | 8,141,397 | Form 13G |
| Perlhagen Gert L. Director | 2020-12-21 16:02:58 | 4,829,200 0 | 4,829,200 | Form 13D |
| Volati Ltd 10% Owner | 2017-03-09 09:07:35 | 1,922,706 0 | 1,922,706 | Form 13D |
| Palti Yoram Chief Technology Officer | 2018-08-30 16:09:04 | 0 1,041,054 | 1,041,054 | Form 4 |
| DOYLE WILLIAM F Executive Chairman | 2022-08-03 16:44:45 | 551,176 0 | 551,176 | Form 4 |
| Ambrogi Michael J. Chief Operating Officer | 2020-07-23 19:43:45 | 395,237 0 | 395,237 | Form 4 |
| Kirson Eilon D. Chief Science Officer | 2019-03-01 16:34:12 | 166,296 0 | 166,296 | Form 4 |
| GROENHUYSEN WILHELMUS CM Chief Operating Officer | 2023-01-10 16:17:15 | 165,126 0 | 165,126 | Form 4 |
| Shah Pritesh Chief Commercial Officer | 2023-01-09 18:20:06 | 82,843 0 | 82,843 | Form 4 |
| LEUNG GABRIEL Director | 2022-06-10 16:09:13 | 79,636 0 | 79,636 | Form 4 |
| Cordova Ashley Chief Financial Officer | 2023-01-10 16:18:06 | 74,442 0 | 74,442 | Form 4 |
| Leonard Frank X President CNS Cancers US | 2023-01-09 18:21:59 | 74,299 0 | 74,299 | Form 4 |
| Longsworth Todd Christopher General Counsel | 2022-03-09 16:50:03 | 62,462 0 | 62,462 | Form 4 |
| Burke William Patrick Chief Human Resources Officer | 2023-01-10 16:13:50 | 55,594 0 | 55,594 | Form 4 |
| Weinberg Uri Chief Science Officer | 2023-01-09 18:24:06 | 45,232 0 | 45,232 | Form 4 |
| Langloss Timothy J. Director | 2016-05-09 16:05:38 | 35,548 0 | 35,548 | Form 4 |
| Pomona Capital VII L.P. Pomona Capital VII Fund Investors L.P. Pomona Associates VII L.P. Pomona Secondary Associates VII LLC Pomona G.P. Holdings LLC GRANOFF MICHAEL D JANIS FRANCES FUTRELL STEVE 10% Owner | 2019-02-13 11:44:03 | 28,924 0 | 28,924 | Form 13G |
| Benaim Ely Chief Medical Officer | 2023-01-10 16:14:46 | 28,770 0 | 28,770 | Form 4 |
| MYLOD ROBERT J JR Director | 2016-05-06 16:10:27 | 21,500 0 | 21,500 | Form 4 |
| LAVIGNE LOUIS J JR Director | 2018-06-04 20:07:03 | 18,490 0 | 18,490 | Form 4 |
| Ben Arye Barak General Counsel | 2023-01-10 16:20:50 | 17,152 0 | 17,152 | Form 4 |
| Danziger Asaf Chief Executive Officer | 2023-01-09 18:18:44 | 13,622 0 | 13,622 | Form 4 |
| Hung David Director | 2022-06-10 16:11:50 | 13,491 0 | 13,491 | Form 4 |
| VERNON W ANTHONY Director | 2022-06-10 16:10:07 | 8700 0 | 8700 | Form 4 |
| Scannell Timothy J Director | 2022-06-10 16:10:55 | 8700 0 | 8700 | Form 4 |
| Madden Martin J. Director | 2022-06-10 16:12:41 | 8700 0 | 8700 | Form 4 |
| McCoy Sherilyn S Director | 2021-06-11 16:24:30 | 8213 0 | 8213 | Form 4 |
| Burkoth William T. Director | 2019-05-22 16:27:31 | 6145 0 | 6145 | Form 4 |
| PHILLIPS CHARLES G III Director | 2019-12-04 16:23:04 | 3359 0 | 3359 | Form 4 |
| HILLEMAN JERYL L Director | 2022-06-16 16:22:05 | 2537 0 | 2537 | Form 4 |
| Melnyk Peter M. Chief Commercial Officer | 2017-01-06 16:05:52 | 2403 0 | 2403 | Form 4 |